These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32843146)
1. Bretylium, a Class III Antiarrhythmic, Returns to the Market. Thind M; Sullivan RM; Williams RN; Kowey PR Am J Cardiol; 2020 Oct; 133():77-80. PubMed ID: 32843146 [TBL] [Abstract][Full Text] [Related]
2. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium. Lucchesi BR Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259 [TBL] [Abstract][Full Text] [Related]
3. Bretylium tosylate: profile of the only available class III antiarrhythmic agent. Anderson JL Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143 [TBL] [Abstract][Full Text] [Related]
4. Bretylium: a prototype for future development of antidysrhythmic agents. Patterson E; Lucchesi BR Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235 [No Abstract] [Full Text] [Related]
5. Advanced cardiac life support controversy: where do antiarrhythmic agents fit in? Chow MS Pharmacotherapy; 1997; 17(2 Pt 2):84S-88S; discussion 89S-91S. PubMed ID: 9085344 [TBL] [Abstract][Full Text] [Related]
6. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias. Heissenbuttel RH; Bigger JT Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436 [TBL] [Abstract][Full Text] [Related]
8. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Singh BN; Collett JT; Chew CY Prog Cardiovasc Dis; 1980; 22(4):243-301. PubMed ID: 6986060 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias. Nolan PE Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342 [TBL] [Abstract][Full Text] [Related]
10. Management of ventricular dysrhythmias in the prehospital and emergency department setting. Mayer NM Am J Cardiol; 1984 Jul; 54(2):34A-36A. PubMed ID: 6464998 [TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic and electrophysiologic effects of MDL 11,939, a novel class III antiarrhythmic agent in anesthetized dogs. Koerner JE; Dage RC J Cardiovasc Pharmacol; 1990 Sep; 16(3):383-93. PubMed ID: 1700208 [TBL] [Abstract][Full Text] [Related]
12. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate. Patterson E; Gibson JK Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294 [TBL] [Abstract][Full Text] [Related]
13. New drugs for treatment of ventricular arrhythmias. Heger JJ; Prystowsky EN; Zipes DP Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255 [TBL] [Abstract][Full Text] [Related]
15. Arrhythmia and acute coronary syndrome suppression and cardiac resuscitation management with bretylium. Bacaner M; Dembo DH Am J Ther; 2009; 16(6):534-42. PubMed ID: 19542875 [TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology. Mason DT; DeMaria AN; Amsterdam EA; Zelis R; Massumi RA Drugs; 1973; 5(4):261-91. PubMed ID: 4146767 [No Abstract] [Full Text] [Related]
17. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312 [TBL] [Abstract][Full Text] [Related]
18. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360. Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718 [TBL] [Abstract][Full Text] [Related]
19. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart. Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111 [TBL] [Abstract][Full Text] [Related]
20. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy. Anderson JL Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]